| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |